Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with a buy rating.
NEW YORK, May 6, 2013 /PRNewswire/ -- Today Highline Research Advisors initiated coverage through Empire Asset Management Company, a FINRA member (143007) of Trovagene (NASDAQ:TROV) with a BUY rating and 12 month price target of $17.00
SOURCE Empire Asset Management Company
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
Newsrooms &
Influencers
9k+
Digital Media
Outlets
Digital Media
Outlets
270k+
Journalists
Opted In
Journalists
Opted In
Share this article